Claritev (NYSE:CTEV) 2026 Investor Day March 16, 2026 01:00 PM ET Company ParticipantsBrad Ross - General Manager of the Payment and Revenue IntegrityBrian Burnside - CEOCarol Nutter - Chief People OfficerDoug Garis - EVP and CFOFernando Schwartz - Chief AI OfficerJay Hodges - CFOJerry Hogge - COOJigar Patel - Chief Medical Officer and Chief Product OfficerMichael Kim - Chief Digital OfficerMike Feeney - FounderSarah Michaels - Chief Clinical OfficerSean Crandall - General Manager and SVP of Claims Intellig ...

Summary of Claritev (NYSE:CTEV) FY Conference Call Company Overview - **Company Name**: Claritev (formerly MultiPlan) - **Industry**: Healthcare technology and services - **Key Executives**: Travis Dalton (President and CEO), Doug Garis (CFO) Core Points and Arguments Company Vision and Strategy - Claritev focuses on transparency and affordability in healthcare, emphasizing clear insights around pricing for employers managing risk and employee benefits [1][2] - The company serves over 700 payer clients and has a provider network of 1.4 million, which is considered a key asset that has been underinvested in [2][3] - The leadership aims to build a sustainable growth company rather than engage in financial engineering, focusing on long-term value creation [4][5] Financial Performance - The company reported a stock increase of 180%-190% year-over-year, indicating strong market performance [3] - In Q3, revenue grew by 7% with record EBITDA, marking the strongest revenue print in absolute dollar terms over the last 12 quarters [26][27] - The company has invested significantly in technology, with $500 million spent over five years and an additional $100 million planned for technology transformation [28] Technology and Innovation - Claritev is transitioning to Oracle Cloud, enhancing its technology infrastructure and enabling faster product development, such as the Network Builder tool [9][50] - The company is focused on integrating AI into its workflows to improve efficiency and service delivery [32] - New product launches and enhancements are planned, with over 30 solution enhancements and 10 new products expected this year [22] Market Position and Growth Opportunities - The company is well-positioned to address challenges in the healthcare market, including cost inflation and regulatory changes, with products that enhance affordability and transparency [8][9] - Claritev's revenue model is based on a percentage of savings (P-save), making it a sticky and profitable business [28][29] - The company is expanding its addressable market by selling existing products into new verticals and international markets without significant customization [19][20] Client Relationships and Sales Strategy - A new client success organization has been established to enhance service for existing clients, leading to multi-year renewals for top clients [44][46] - The sales pipeline has grown significantly, with over 20 new logos acquired in the first three quarters of the previous year [40] Future Outlook - The leadership emphasizes a focus on execution in 2026, aiming for strong financial growth and product innovation [53][54] - Employee satisfaction and engagement are also key focuses, with the belief that a committed workforce will drive long-term success [55][56] Additional Important Content - The company has a high provider acceptance rate, with over 90% of transactions proceeding smoothly [23][24] - Claritev's competitive advantage lies in its extensive data rights agreements and custom business rules developed over years of service [23] - The leadership team has been restructured to enhance focus and drive growth, with a commitment to transparency and accountability in operations [39][42]

Claritev Corporation (NYSE:CTEV) FY Conference Summary Company Overview - **Company**: Claritev Corporation - **Industry**: Healthcare IT and Services - **Focus**: Affordability and transparency in the healthcare market - **Key Customers**: Recently renewed contracts with top 10 customers, which comprise 70% of revenue [4][5] Core Insights and Arguments - **Customer Relationships**: The renewal of top clients is viewed as a foundation for growth rather than merely retaining clients. The company aims to expand its business with these clients [6][8] - **Pipeline Growth**: The business has seen a dramatic increase in its pipeline, up 67% over the last year, with half of this growth coming from existing clients [5][6] - **Value Proposition**: Claritev's offerings are designed to reduce healthcare costs and provide transparency, which is increasingly valuable in a market facing rising costs [5][8] - **Revenue Model**: The PSAV model generates 88% of revenue and is based on savings achieved for clients, aligning incentives with out-of-network claims management [13][18] - **R&D Investment**: The company invests $170 million annually in R&D to enhance its product offerings, which supports its competitive positioning [9][18] Financial Performance - **Medical Charges Processed**: Grew 7% year-over-year in 2024 and 8.5% year-to-date in 2025, driven by healthcare inflation and a higher mix of out-of-network claims in specific care categories [26][27] - **Identified Savings**: Approximately $25 billion in savings identified last year, showcasing the company's impact on healthcare costs [24][25] - **Future Projections**: Anticipated stable out-of-network spend growth of 5%-7% over the next few years, with a focus on maintaining a stable claims volume [28][39] Regulatory Environment - **NSA and Price Transparency**: The company views recent regulations as an opportunity for growth, particularly at the state level, and is well-positioned to navigate these changes [42][43] - **Competitive Advantage**: Claritev believes it has a competitive edge in managing claims under the NSA due to its established processes and extensive provider network [44][45] Strategic Initiatives - **Market Expansion**: The company has launched six new verticals this year, aiming to diversify its offerings and enhance its market presence [30][52] - **Sales Function Development**: The establishment of a true sales function is expected to drive growth, with a focus on multiple product categories and increased sales force size [51][54] - **Bookings to Revenue Conversion**: The company plans to provide clearer metrics on bookings to revenue conversion in its upcoming Q4 earnings report [55] Additional Considerations - **Healthcare Trends**: The macroeconomic pressures in healthcare are expected to drive demand for Claritev's services, as employers seek solutions to rising costs [30][34] - **Client Management**: The company emphasizes the importance of strategic partnerships and the scale advantages they provide in managing healthcare costs effectively [24][39] This summary encapsulates the key points discussed during the conference, highlighting Claritev's strategic positioning, financial performance, and outlook in the healthcare IT industry.

Claritev Corporation (NYSE:CTEV) 2025 Conference Summary Company Overview - **Company**: Claritev Corporation - **Industry**: Healthcare Technology and Services - **Conference Date**: December 02, 2025 Key Points Company Performance and Strategy - 2024 was a foundational year for Claritev, while 2025 marked a significant turnaround, focusing on sustainable growth [3][4] - The company has identified its core business as a growth business, managing five internal P&Ls and opening six new market segments [4][5] New Market Segments - Claritev has expanded into six new market segments, including: 1. **Provider Market**: Introduction of a transparency product called CompleteView for pricing transparency [9] 2. **International Market**: Advanced Code Editing product aimed at denial management for providers, particularly in the Middle East [10][11] 3. **Government Segment**: Selling core products to federal agencies, with a notable win expected to be announced in Q4 [11] 4. **Employer Space**: BenInsights platform for self-insured employers to manage healthcare costs [12] Financial Metrics - The company expects to book at least $60 million in Annual Contract Value (ACV) for 2025, with 491 deals closed year-to-date averaging $80,000-$90,000 [24][26] - The pipeline is approximately $200 million, with 55% from the current install base [26] International Expansion - Claritev is leveraging previous relationships to explore international markets, particularly focusing on denial management solutions [15][16] - The company aims to address inefficiencies in healthcare systems in about three dozen countries that have adopted U.S. coding standards [16] Competitive Advantage - Claritev's Advanced Code Editing has shown significant results, reducing denial rates for Burjeel Holdings from 7% to 3.5%, translating to $40 million in economic value [18][19] - The company is positioned uniquely in the market, focusing on direct-to-provider solutions rather than traditional methods of managing denials [19] Technology and Partnerships - A strategic partnership with Oracle has enabled rapid deployment of technology solutions, enhancing operational efficiency [34][35] - The relationship with Oracle is evolving into a go-to-market strategy, with Oracle Cloud representatives now selling Claritev's solutions [35] Operational Improvements - The company has focused on improving its financial operations and accountability, leading to a more efficient structure with 3% less headcount while growing the business [43][44] - Emphasis on mastering the basics, including the use of Salesforce for pipeline management, has been crucial for stabilization [45][46] Future Outlook - Claritev views its entire business as a growth opportunity, with significant potential in the network business and government sector [51][52] - The company is optimistic about its ability to accelerate investments in international markets as it gains proof of value [17][46] Additional Insights - The healthcare industry is facing significant challenges, with denial rates being a critical issue for providers [20][21] - Claritev's solutions are designed to optimize cash flow for providers, addressing both payer and provider needs [22][21] - The company is committed to making healthcare more transparent and affordable, which is reflected in its strategic partnerships and product offerings [48][49]

Investor Presentation Company Overview September 3, 2025 1 Disclaimer Forward-Looking Statements This presentation includes statements that express our management's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements." These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "ant ...